Not wrong. I posted the following list about a year ago of...

Not wrong. I posted the following list about a year ago of capital raised by Lucapa over the last 10 years. It may not be entirely correct or complete, so DYOR.

Keep in mind that the Mothae acquisition was announced in January 2017, so it would be fair to say that capital raised has, at least in part, repaid the development costs and debt funding for Mothae.

LOM has stated it is doing a strategic review of the Mothae 'asset' - that will be interesting. How deep will the strategic review dive, and can we expect the report to be publicly released?

I think it's pretty clear that Lucapa would not have a market cap under $30m, while boasting 'debt free status', if Mothae was generating even a modest return on investment. The broad uncertainty about the viability of Mothae, and the cash position of Mothae and Lucapa, are IMO, some of the fetters to Lucapa's share price at the moment.

Capital raised since August 2013.

1. $1.3m placement in August 2013
2. $1.4m placement in November 2013
3. $5.5m placement in April 2014
4. $4m placement in July 2015
5. $16.5m placement in April 2018
6. $5.25m through a rights issue in June 2020.
7. $10m through a placement in November 2020
8. $23m through a $20m placement and $3m SPP in May 2021
9. $12.5m through a placement in March 2022
Total: $79.45m

This does not include:
1. USD $15m financing facility announced in January 2015 for Lulo
2. USD $7m debt funding from IDC in December 2018
3. USD $15m debt funding from Equigold
4. AUD $15m (+4m) funding package for Mothae – underwriting of LOMOA options, loan facility with First Class Securities, and other options.